---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-040757"
form_type: "8-K"
ticker: "COCP"
cik: "0001412486"
company_name: "Cocrystal Pharma, Inc."
filed_at: "2024-10-10T23:59:59+00:00"
generated_at: "2026-05-30T16:30:54.516493+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Cocrystal Pharma ratifies exec salary hikes to $416K, $200K bonuses, and RSU grants

## Summary
- James Martin (CFO/co-CEO) and Dr. Sam Lee (President/co-CEO) base salary increased from $400K to $416K, plus $200K bonus and 40,000 RSUs each.
- Non-employee director grants: Dr. Kornberg $60.5K cash + $100K SAB stipend + 28,109 RSUs; Dr. Frost $44,770 + 27,100 RSUs; Steven Rubin $82,280 + 18,957 RSUs.
- Other director grants: Fred Hassan $36,300 + 8,067 RSUs; Richard Pfenniger $36,300 + 8,067 RSUs; Dr. Japour $54,450 + 14,924 RSUs.
- Half of each RSU grant vested immediately; remaining half vests quarterly over two years starting Sep 30, 2025.

## SEC filing metadata
- accession: 0001493152-24-040757
- form_type: 8-K
- ticker: COCP
- cik: 0001412486
- company_name: Cocrystal Pharma, Inc.
- filed_at: 2024-10-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412486/000149315224040757/0001493152-24-040757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412486/000149315224040757/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-040757
- JSON: https://secwatch.observer/filing/0001493152-24-040757.json
- Plain text: https://secwatch.observer/filing/0001493152-24-040757.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.